Investment Banking

Quest Cap Inc

Investment Banking


Medivolve Inc. (NEO:MEDV; OTC:COPRF; FRA:34C1)  seeks out disruptive technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate remarkable risk-adjusted returns for investors. Specifically, Medivolve offers investors a diversified investment in the COVID-19 medical space across three areas; prevention, detection, and treatment.

Medivolve has a team of renowned global medical and business advisors that have developed a proprietary business strategy to capitalize on high-margin opportunities in the COVID-19 space.  This panel includes prominent immunologist Dr. Lawrence Steinman and Dr. Glenn Copeland, who has 45 years of experience in orthopaedic treatment, foot and ankle care, and sports medicine.

Medivolve’s primary focus is to provide convenient and assessable medical services for testing of the COVID-19 virus to help combat the pandemic. This is achieved largely through two acquisitions: 100% of Collection Sites, LLC and 28% of Colombian Sanaty IPS. Collection Sites is setting up a series of COVID-19 testing sites across the United States with appointments and payments will be handled through the online portal Sanaty is setting up a series of full-service medical clinics offering a complete COVID-19 testing solution.

Company Data

Latest news

Medivolve Announces Rebrand, Affirms Momentum in Health-Tech Space Under New Leadership


TAGS : Health & Biotechnology

Medivolve Closes Acquisition of Industry-Leading Electronic Health Platform as Next Step in Transforming Human Health Management Across the United States


TAGS : Health & Biotechnology

Medivolve Expands Portfolio of Pharmacy Acquisitions with Agreement to Acquire Outstanding Shares of CalVax Licensed Marbella Pharmacy


TAGS : Health & Biotechnology

Medivolve Signs Agreement to Acquire Industry-Leading Electronic Health Platform


TAGS : Health & Biotechnology

Medivolve Announces an Investor Webinar - Tuesday, May 11 at 11 am ET


TAGS : Health & Biotechnology